综述
ENGLISH ABSTRACT
宏基因组高通量测序技术在革兰阴性菌耐药表型检测中的研究进展
梁文炎
施毅
孙文逵
作者及单位信息
·
DOI: 10.3760/cma.j.cn112147-20210705-00468
Progress of metagenomics next-generation sequencing in the detection of drug-resistant phenotypes of Gram-negative bacteria
Liang Wenyan
Shi Yi
Sun Wenkui
Authors Info & Affiliations
Liang Wenyan
Department of Respiratory & Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
Shi Yi
Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China
Sun Wenkui
Department of Respiratory & Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
·
DOI: 10.3760/cma.j.cn112147-20210705-00468
1638
284
0
0
6
8
PDF下载
APP内阅读
摘要

耐药细菌感染的不断蔓延对公共卫生安全构成重要威胁,早期诊断和目标治疗是治疗成功的关键。传统细菌培养及药物敏感性检测耗时长、敏感性不高,无法满足临床诊治需求,高通量测序等分子检测技术成为新的发展方向。本文对近年来有关高通量测序在革兰阴性菌耐药诊治中的进展做一综述。

ABSTRACT

The ongoing spread of drug-resistant bacterial infections poses a significant threat to public health, and early diagnosis and targeted treatment are the keys to successful treatment. Traditional bacterial culture and drug susceptibility testing is time-consuming and insensitive, and cannot meet the needs of clinical diagnosis and treatment, so molecular detection technologies, such as metagenomics next-generation sequencing, have become a new research direction. This article reviewed recent advances in high-throughput sequencing for the diagnosis and treatment of drug resistance in Gram-negative bacteria.

Sun Wenkui, Email: nc.defudabe.umjniuknewnus
引用本文

梁文炎,施毅,孙文逵. 宏基因组高通量测序技术在革兰阴性菌耐药表型检测中的研究进展[J]. 中华结核和呼吸杂志,2022,45(02):209-213.

DOI:10.3760/cma.j.cn112147-20210705-00468

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
细菌耐药现象日益常见且已成为全球公共卫生安全最大威胁之一 1。临床实践过程中,广泛耐药革兰阴性菌(extensively drug resistant Gram-negative bacilli,XDR-GNB)作为院内常见复杂耐药菌受到关注,肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌耐药现象尤为严重,已出现对所有抗菌药物耐药的超级菌种 2 , 3 , 4 , 5 , 6。感染性疾病的精准治疗成为临床迫切要求。目前传统的细菌检测手段普遍存在耗时长、敏感性不高等不足,经验性使用广谱抗菌药物是初始抗感染治疗的常用方案。经验性抗感染治疗常导致药物的不恰当使用,不仅延误治疗,也会加重耐药现象。传统细菌及其耐药检测手段已无法满足现今医疗需求,寻找新的快捷、简便检测手段成为了迫切需求,分子检测手段就此进入舞台 7 , 8
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Laxminarayan R , Duse A , Wattal C ,et al. Antibiotic resistance-the need for global solutions[J]. Lancet Infect Dis, 2013,13(12):1057-1098. DOI: 10.1016/S1473-3099(13)70318-9 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Master RN , Deane J , Opiela C ,et al. Recent trends in resistanc e to cell envelope-active antibacterial agents among key bacterial pathogens [J]. Ann N Y Acad Sci, 2013,1277:1-7. DOI: 10.1111/nyas.12022 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Guan X , He L , Hu B ,et al. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement[J]. Clin Microbiol Infect, 2016,22Suppl 1:S15-25. DOI: 10.1016/j.cmi.2015.11.004 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Gibson DJ , Gallagher CG , Doherty GA . Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn′s disease in a patient with pan resistant pseudomonas cystic fibrosis: a case report[J]. J Crohns Colitis, 2014,8(11):1561-1562. DOI: 10.1016/j.crohns.2014.04.011 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Oliva A , Cipolla A , Vullo V ,et al. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia[J]. New Microbiol, 2017,40(3):205-207.
返回引文位置Google Scholar
百度学术
万方数据
[6]
Chen L , Todd R , Kiehlbauch J ,et al. Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase- Producing Klebsiella pneumoniae-Washoe County, Nevada, 2016[J]. MMWR Morb Mortal Wkly Rep, 2017,66(1):33. DOI: 10.15585/mmwr.mm6601a7 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Cansizoglu MF , Tamer YT , Farid M ,et al. Rapid ultrasensitive detection platform for antimicrobial susceptibility testing[J]. PLoS Biol, 2019,17(5):e3000291. DOI: 10.1371/journal.pbio.3000291 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Giordano C , Piccoli E , Brucculeri V ,et al. A prospective evaluation of two rapid phenotypical antimicrobial susceptibility technologies for the diagnostic stewardship of sepsis[J]. Biomed Res Int, 2018,2018:6976923. DOI: 10.1155/2018/6976923 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Chen C , Hong W . Recent Development of rapid antimicrobial susceptibility testing methods through metabolic profiling of bacteria[J]. Antibiotics (Basel), 2021,10(3). DOI: 10.3390/antibiotics10030311 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Shanmugakani RK , Srinivasan B , Glesby MJ ,et al. Current state of the art in rapid diagnostics for antimicrobial resistance[J]. Lab Chip, 2020,20(15):2607-2625. DOI: 10.1039/d0lc00034e .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Caliendo AM , Gilbert DN , Ginocchio CC ,et al. Better tests, better care: improv ed diagnostics for infectious diseases [J]. Clin Infect Dis, 2013,57Suppl 3(Suppl 3):S139-170. DOI: 10.1093/cid/cit578 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Tamma PD , Goodman KE , Harris AD ,et al. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem- Resistant Enterobacteriaceae Bacteremia[J]. Clin Infect Dis, 2017,64(3):257-264. DOI: 10.1093/cid/ciw741 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Yao H , Zhao W , Jiao D ,et al. Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni[J]. J Antimicrob Chemother, 2021,76(3):596-600. DOI: 10.1093/jac/dkaa483 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Mitchell SL , Simner PJ . Next-Generation Sequencing in Clinical Microbiology: Are We There Yet?[J]. Clin Lab Med, 2019,39(3):405-418. DOI: 10.1016/j.cll.2019.05.003 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Hendriksen RS , Bortolaia V , Tate H ,et al. Using Genomics to Track Global Antimicrobial Resistance[J]. Front Public Health, 2019,7:242. DOI: 10.3389/fpubh.2019.00242 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Boolchandani M , D′ Souza AW ,et al. Sequencing-based methods and resources to study antimicrobial resistance[J]. Nat Rev Genet, 2019,20(6):356-370. DOI: 10.1038/s41576-019-0108-4 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Havenga B , Ndlovu T , Clements T ,et al. Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains[J]. BMC Microbiol, 2019,19(1):303. DOI: 10.1186/s12866-019-1687-0 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Mwangi J , Hao X , Lai R ,et al. Antimicr obial peptides: new hope in the war against multidrug resistance [J]. Zool Res, 2019,40(6):488-505. DOI: 10.24272/j.issn.2095-8137.2019.062 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Poirel L , Potron A , Nordmann P . OXA-48-like carbapenemases: the phantom menace[J]. J Antimicrob Chemother, 2012,67(7):1597-1606. DOI: 10.1093/jac/dks121 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Bedenić B , Meštrović T . Mechanisms of resistance in gram-negative urinary pathogens: from country-Specific molecular insights to global clinical relevance[J]. diagnostics (Basel), 2021,11(5):800. DOI: 10.3390/diagnostics11050800 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Cag Y , Caskurlu H , Fan Y ,et al. Resistance mechanisms[J]. Ann Transl Med, 2016,4(17):326. DOI: 10.21037/atm.2016.09.14 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Bonomo RA . β-Lactamases: A Focus on Current Challenges[J]. Cold Spring Harb Perspect Med, 2017,7(1):a025239. DOI: 10.1101/cshperspect.a025239 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Arizpe A , Reveles KR , Patel SD ,et al. Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria [J]. Curr Infect Dis Rep, 2016,18(12):39. DOI: 10.1007/s11908-016-0552-7 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Hou XH , Song XY , Ma XB ,et al. Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates[J]. Braz J Microbiol, 2015,46(3):759-768. DOI: 10.1590/S1517-838246320140138 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Silveira MC , Rocha-de-Souza CM , de Oliveira Santos IC ,et al. Genetic Basis of Antimicrobial Resistant Gram-Negative Bacteria Isolated From Bloodstream in Brazil[J]. Front Med (Lausanne), 2021,8:635206. 10.3389/fmed.2021.635206 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Ruppé É , Woerther PL , Barbier F . Mechanisms of antimicrobial resistance in Gram-negative bacilli[J]. Ann Intensive Care, 2015,5(1):61. DOI: 10.1186/s13613-015-0061-0 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
Sawa T , Kooguchi K , Moriyama K . Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance[J]. J Intensive Care, 2020,8:13. DOI: 10.1186/s40560-020-0429-6 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Hasman H , Saputra D , Sicheritz-Ponten T ,et al. Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples[J]. J Clin Microbiol, 2014,52(1):139-146. DOI: 10.1128/JCM.02452-13 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
Feigelman R , Kahlert CR , Baty F ,et al. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details[J]. Microbiome, 2017,5(1):20. DOI: 10.1186/s40168-017-0234-1 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
Chao L , Li J , Zhang Y ,et al. Application of next generation sequencing-based rapid detection platform for microbiological diagnosis and drug resistance prediction in acute lower respiratory infection[J]. Ann Transl Med, 2020,8(24):1644. DOI: 10.21037/atm-20-7081 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
中华医学会检验医学分会. 高通量宏基因组测序技术检测病原微生物的临床应用规范化专家共识[J]. 中华检验医学杂志, 2020,43(12):1181-1195. DOI: 10.3760/cma.j.cn114452-20200903-00704 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
宏基因组学测序技术在中重症感染中的临床应用共识专家组,中国研究型医院学会脓毒症与休克专业委员会,中国微生物学会微生物毒素专业委员会,. 宏基因组学测序技术在中重症感染中的临床应用专家共识(第一版)[J]. 中华危重病急救医学, 2020,32(5):531-536. DOI: 10.3760/cma.j.cn121430-20200228-00095 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
中华医学会检验医学分会临床微生物学组,中华医学会微生物学与免疫学分会临床微生物学组,中国医疗保健国际交流促进会临床微生物与感染分会. 宏基因组高通量测序技术应用于感染性疾病病原检测中国专家共识[J]. 中华检验医学杂志, 2021,44(2):107-120. DOI: 10.3760/cma.j.cn114452-20201026-00794 .
返回引文位置Google Scholar
百度学术
万方数据
[34]
Hammoudi Halat D , Ayoub Moubareck C . The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria[J]. Antibiotics (Basel), 2020,9(4):186. DOI: 10.3390/antibiotics9040186 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Queenan AM , Bush K . Carbapenemases: the versatile beta-lactamases[J]. Clin Microbiol Rev, 2007,20(3):440- 458, table of con tents . DOI: 10.1128/CMR.00001-07 .
返回引文位置Google Scholar
百度学术
万方数据
[36]
Jacoby GA , Munoz-Price LS . The new beta-lactamases[J]. N Engl J Med, 2005,352(4):380-391. DOI: 10.1056/NEJMra041359 .
返回引文位置Google Scholar
百度学术
万方数据
[37]
Su M , Satola SW , Read TD . Genome-Based Prediction of Bacterial Antibiotic Resistance[J]. J Clin Microbiol, 2019,57(3):e01405-18. DOI: 10.1128/JCM.01405-18 .
返回引文位置Google Scholar
百度学术
万方数据
[38]
Kaprou GD , Bergšpica I , Alexa EA ,et al. Rapid Methods for Antimicrobial Resistance Diagnostics[J]. Antibiotics (Basel), 2021,10(2):209. DOI: 10.3390/antibiotics10020209 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
孙文逵,Email: nc.defudabe.umjniuknewnus
B

梁文炎, 施毅, 孙文逵. 宏基因组高通量测序技术在革兰阴性菌耐药表型检测中的研究进展[J]. 中华结核和呼吸杂志, 2022, 45(2): 209-213. DOI: 10.3760/cma.j.cn112147-20210705-00468.

C
所有作者声明无利益冲突
D
国家自然科学基金 (81770009)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号